3D microtumors
Next-Gen Drug Testing: Scientists Bioprint Long-Term Colon Cancer Models
Imagine a world where we can mimic the way cancer grows and evolves in the human body without actually relying on human trials. Building on this vision, scientists from CTIBiotech…
A Guide to Bioprinting: Understanding a Booming Industry
The success of bioprinting could become the key enabler that personalized medicine, tissue engineering, and regenerative medicine need to become a part of medical arsenals. Breakthroughs in bioprinting will enable…
CELLINK in France: Expanding Their Portfolio in 2020
Seeking to strengthen their presence in Europe, 3D bioprinter provider and pioneer bioink company CELLINK, opened their new offices in Lyon, France, last October. Begining new partnerships and collaborations with…
Interview: CTIBiotech’s 3D Microtumors Can Aid in the Fight Against Cancer
Understanding cancer cells is a fundamental part of looking for ways to cure the disease, which has been around for a long time. Cancer is the second leading cause of…
